Patents by Inventor Wolfgang Koerwer

Wolfgang Koerwer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ancrod proteins, their preparation and use
    Patent number: 6015685
    Abstract: Pure glycosylated, partially glycosylated or unglycosylated polypeptides have the amino-acid sequence of ancrod, in which up to 5 amino acid residues can be replaced by residues of other natural amino acids, and are suitable for controlling diseases.
    Type: Grant
    Filed: May 14, 1991
    Date of Patent: January 18, 2000
    Assignee: BASF Aktiengesellschaft
    Inventors: Alfred Bach, Karl-Hermann Strube, Wolfgang Koerwer
  • Hirudin/polyalkylene glycol conjugates and hirudin muteins
    Patent number: 5663141
    Abstract: Hirudin/polyalkylene glycol derivatives of the formula[A--(CH.sub.2).sub.n --[O--(CH.sub.2).sub.nlm --B--].sub.p Hir [sic]Iand hirudin muteins and the preparation thereof are described. The compounds are suitable for controlling diseases.
    Type: Grant
    Filed: May 29, 1992
    Date of Patent: September 2, 1997
    Assignee: BASF Aktiengesellschaft
    Inventors: Manfred Kurfuerst, Klaus Ruebsamen, Bernhard Schmied, Wolfgang Koerwer, Juergen Schweden, Hans Wolfgang Hoeffken
  • Hirudin fusion proteins and preparation of hirudin
    Patent number: 5624822
    Abstract: Fusion proteins composed of protein A and hirudin peptides are used to prepare hirudin peptides.
    Type: Grant
    Filed: June 20, 1994
    Date of Patent: April 29, 1997
    Assignee: BASF Aktiengesellschaft
    Inventor: Wolfgang Koerwer
  • Thrombin-inhibitory protein from ticks
    Patent number: 5585350
    Abstract: A novel thrombin inhibitory protein from ticks with a molecular weight of about 26000 dalton and the partial amino acid sequences Val-Ala-Lys-Phe-Ala-X-Asn-Ser-Gly-Ser-Glu-Thr-Gly (SEQ ID NO: 8), His-Ala-Y-Phe-Glu (SEQ ID NO: 3), Arg-Val-Ser-Asp-Phe-Glu (SEQ ID NO: 4), Phe-Val-Tyr-Thr-Ile-Glu (SEQ ID NO: 6), where X and Y can be identical or different and each is a naturally occurring amino acid, is suitable for controlling diseases.
    Type: Grant
    Filed: March 18, 1994
    Date of Patent: December 17, 1996
    Assignee: BASF Aktiengesellschaft
    Inventors: Thomas Friedrich, Wolfgang Koerwer, Burkhard Kroeger, Siegfried Bialojan
  • N-terminal deletions of lymphotoxin, their preparation and use
    Patent number: 5157106
    Abstract: Polypeptides which differ from lymphotoxin by the absence of amino acids at the N-terminal end of the lymphotoxin are described. The polypeptides can be prepared by gene manipulation and are suitable, alone or in combination with lymphokines, as pharmaceuticals.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: October 20, 1992
    Assignee: BASF Aktiengesellschaft
    Inventors: Klaus Schollmeier, Achim Moeller, Wolfgang Koerwer, Thomas Doerper, Heinz Hillen, Lothar Daum, Franz Emling, Gerhard Keilhauer